Ausgabe Sonderheft 4/2008
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Inhalt (5 Artikel)
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Reuben Ramphal
An overview of harms associated with β-lactam antimicrobials: where do the carbapenems fit in?
Robert C Owens Jr
The role of carbapenems in initial therapy for serious Gram-negative infections
James J Rahal